Avalo Therapeutics, Inc. Common Stock

AVTXNASDAQUSD
14.49 USD
0.03 (0.21%)🟢PRE MARKET (AS OF 04:01 AM EDT)
🟢Market: OPEN
Open?$14.39
High?$14.39
Low?$14.39
Prev. Close?$14.42
Volume?1
Avg. Volume?834.5K
VWAP?$14.39
Rel. Volume?0.00x
Bid / Ask
Bid?$14.08 × 100
Ask?$14.47 × 100
Spread?$0.39
Midpoint?$14.28
Valuation & Ratios
Market Cap?328.6M
Shares Out?26.7M
Float?21.2M
Float %?86.6%
P/E Ratio?N/A
P/B Ratio?3.96
EPS?-$3.43
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.13Strong
Quick Ratio?8.13Strong
Cash Ratio?1.23Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
58/100
P/E?
N/A
P/B?
3.96FAIR
P/S?
5,569.65HIGH
P/FCF?
N/A
EV/EBITDA?
-4.3CHEAP
EV/Sales?
5,300.87HIGH
Returns & Efficiency
ROE?
-94.2%WEAK
ROA?
-67.2%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$312.8M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
317.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707